Literature DB >> 11377064

Determination of an echinocandin, MK-0991, in mammalian plasma by radioimmunoassay.

A S Yuan1, D Cylc, J Y Hsieh, B K Matuszewski.   

Abstract

A quantitative method based on radioimmunoassay for the determination of the antifungal agent, CANCIDAS (MK-0991) has been developed and validated. The immunogen was prepared by coupling MK-0991 to bovine serum albumin through a two-step reaction with difluorodinitrobenzene. An antiserum specific to MK-0991 was selected for RIA. The assay was based on the competitive immunoassay principle in which the drug competes with iodinated drug for a limited quantity of specific antibody. The bound tracer was separated via goat anti-rabbit globulin. The assay demonstrates good accuracy and reproducibility at plasma concentration down to 10 ng/ml. The specificity of the RIA method was confirmed by cross-validating against an established HPLC method.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11377064     DOI: 10.1016/s0731-7085(01)00344-2

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  2 in total

1.  Cryptococcus neoformans resistance to echinocandins: (1,3)beta-glucan synthase activity is sensitive to echinocandins.

Authors:  Marybeth A Maligie; Claude P Selitrennikoff
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

2.  Disposition of caspofungin, a novel antifungal agent, in mice, rats, rabbits, and monkeys.

Authors:  Punam Sandhu; Xin Xu; Peter J Bondiskey; Suresh K Balani; Michael L Morris; Yui S Tang; Alisha R Miller; Paul G Pearson
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.